Accumulating evidence indicates that besides EGFR activation, the mesenchymal-to-epithelial transition factor (c-Met) and its ligand, hepatocyte growth factor (HGF), are also aberrantly activated in HNSCC. The gene discussed is MET; the disease is head and neck squamous cell carcinoma.